Rubicon Research acquires 85% stake in Ahmedabad-based Arinna Lifesciences for ₹176 cr

Arinna’s domestic sales and distribution platform is expected to provide Rubicon access to Indian patients and prescribers for its differentiated offerings Read More | Source: The Hindu Business Line